Tina Marriott Larson is President & COO at RECURSION PHARMACEUTICALS, INC. (RXRX). They have made 7 open-market trades across 1 company since 2021, most recently 2024-01-25.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RXRX | 422,584 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2024-01-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RXRX | SELL · 10b5-1 | 2024-01-25 | 2024-01-29 | $10.35 | $83K | -6.1% | +22.8% | -22.2% |
| RXRX | SELL · 10b5-1 | 2023-12-28 | 2024-01-02 | $10.58 | $85K | +16.6% | -0.2% | -2.1% |
| RXRX | SELL · 10b5-1 | 2023-11-16 | 2023-11-17 | $6.76 | $20K | -3.1% | +33.7% | +75.8% |
| RXRX | SELL · 10b5-1 | 2023-10-26 | 2023-10-30 | $5.63 | $17K | +0.2% | +35.1% | +106.1% |
| RXRX | SELL · 10b5-1 | 2023-09-28 | 2023-10-02 | $7.72 | $23K | -11.2% | -28.6% | +38.4% |
| RXRX | SELL · 10b5-1 | 2023-08-24 | 2023-08-28 | $8.66 | $26K | -5.2% | -8.5% | -23.2% |
| RXRX | SELL · 10b5-1 | 2023-07-27 | 2023-07-28 | $13.78 | $170K | -17.3% | -35.1% | -58.2% |
| RXRX | SELL · 10b5-1 | 2023-06-29 | 2023-07-03 | $7.49 | $22K | +60.8% | +78.0% | -3.2% |
| RXRX | SELL · 10b5-1 | 2023-05-31 | 2023-06-02 | $8.63 | $26K | +20.2% | -10.0% | +6.1% |
| RXRX | SELL | 2023-02-23 | 2023-02-27 | $7.82 | $63K | -5.9% | -15.3% | +10.7% |
| RXRX | SELL | 2023-01-26 | 2023-01-27 | $8.07 | $65K | -1.5% | -8.4% | -42.0% |
| RXRX | SELL | 2022-12-29 | 2022-12-30 | $7.70 | $62K | +12.1% | +3.7% | -17.0% |
| RXRX | SELL | 2022-11-17 | 2022-11-17 | $10.96 | $175K | -16.0% | -32.0% | -24.6% |
| RXRX | SELL | 2022-10-27 | 2022-10-28 | $10.72 | $172K | -6.1% | -23.2% | -24.9% |
| RXRX | SELL | 2022-09-29 | 2022-10-03 | $10.86 | $347K | -2.0% | -8.0% | -32.9% |
| RXRX | SELL | 2022-08-16 | 2022-08-17 | $12.60 | $202K | -8.4% | -3.0% | +6.6% |
| RXRX | SELL · 10b5-1 | 2021-12-16 | 2021-12-20 | $18.74 | $47K | -12.2% | -37.2% | -66.1% |
| RXRX | SELL · 10b5-1 | 2021-11-18 | 2021-11-22 | $18.92 | $47K | +5.8% | +9.3% | -39.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.